
Oseflu75 mg
Beximco Pharmaceuticals Ltd.
Oseltamivir is indicated for the treatment and prevention of influenza in adults and children.
Oseltamivir is indicated for the treatment and prevention of influenza in adults and children. Its use is classified below by strength of evidence:
Oseltamivir is not effective against the common cold or other respiratory illnesses not caused by influenza virus, and should not be used empirically without a reasonable suspicion of influenza.
| Age/Weight | Dose | Duration |
|---|---|---|
| Adults and adolescents ≥13 years | 75 mg orally twice daily | 5 days |
| Children >40 kg | 75 mg twice daily | 5 days |
| Children >23-40 kg | 60 mg twice daily | 5 days |
| Children >15-23 kg | 45 mg twice daily | 5 days |
| Children ≤15 kg (1-12 years) | 30 mg twice daily | 5 days |
| Infants 2 weeks to 1 year | 3 mg/kg twice daily (weight-based, per physician) | 5 days |
Treatment should begin as soon as possible, ideally within 48 hours of symptom onset, although it may still be prescribed later in high-risk or hospitalized patients under physician judgment.
| Age/Weight | Dose | Duration |
|---|---|---|
| Adults and children ≥40 kg or ≥13 years | 75 mg once daily | At least 10 days after exposure; up to 6 weeks during a community outbreak, per physician |
| Children 1-12 years (weight-based) | Same weight bands as treatment, given once daily instead of twice daily | 10 days |
Dose reduction is required based on creatinine clearance (CrCl); see Use in Special Populations for details. No adjustment is needed for mild hepatic impairment.
Oseltamivir should be taken exactly as prescribed by a physician for the full duration, and not stopped early even if symptoms improve, to ensure adequate antiviral effect.
Common side effects of Oseltamivir include:
Less common but serious effects include:
Patients or caregivers should seek prompt medical attention for any unusual behavior, severe rash, or signs of an allergic reaction while taking Oseltamivir.
Oseltamivir is contraindicated in patients with known hypersensitivity to Oseltamivir or any component of the formulation.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.